Lok N Store Share News (LOK)

Edith Shih, a Non-Executive Director and Company Secretary of Hutchison China MediPharma, acquired 20,000 shares in the firm, which is the holding company of a healthcare group based primarily in China and focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.Shih acquired the shares for 620p a piece, giving a total trade value of £124,000. The purchased shares represent her entire holding in the group. The transaction was made one week after a business majority owned by Hutchison China MediPharma entered into a licensing, co-development, and commercialisation agreement with US pharmaceutical manufacturer Eli Lilly. The agreement relates to Fruquintinib, an oncology therapy for the potential treatment of various types of solid tumours.Fruquintinib was discovered by Hutchison MediPharma and is currently in Phase II testing in China.Under the agreement, the two will share the costs of future development and Hutchison will receive a series of payments of up to $86.5m, including upfront payments and development and regulatory approval milestones. Top Director BuysVesuvius (VSVS) Director name: Mr Chris O'SheaAmount purchased: 29,672 @ 459.89p Value: £136,459Hutchison China Meditech Ltd (HCM) Director name: Ms Edith ShihAmount purchased: 20,000 @ 620.00p Value: £124,000Synety Group (SNTY) Director name: Mr Paul Williams Amount purchased: 11,240 @ 133.45p Value: £15,000DDD Group (DDD) Director name: Mr Nicholas O BrigstockeAmount purchased: 200,000 @ 6.00p Value: £12,000Top Director SellsLok'n Store Group (LOK) Director name: Mr Simon ThomasAmount sold: 100,000 @ 187.00p Value: £187,000MyCelx Technologies Corporation (DI) (MYX) Director name: Mr Mark ClarkAmount sold: 33,333 @ 500.00p Value: £166,665Dairy Farm International Holdings Ltd. (Singapore) (DFI) Director name: Mr Michael KokAmount sold: 4,500 @ $10.64 Value: $47,898Lok'n Store Group (LOK) Director name: Mr Ray DaviesAmount sold: 15,000 @ 183.00p Value: £27,450NR